These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Transdermal scopolamine as a cause of transient psychosis in two elderly patients. Mego DM, Omori JM, Hanley JF. South Med J; 1988 Mar 22; 81(3):394-5. PubMed ID: 3347867 [Abstract] [Full Text] [Related]
16. Transdermal scopolamine intoxication in a child. Klein BL, Ashenburg CA, Reed MD. Pediatr Emerg Care; 1985 Dec 22; 1(4):208-9. PubMed ID: 3842169 [No Abstract] [Full Text] [Related]
17. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Avunduk AM, Tekelioglu Y, Turk A, Akyol N. Clin Ther; 2005 Sep 22; 27(9):1392-402. PubMed ID: 16291412 [Abstract] [Full Text] [Related]
18. Transderm-induced psychosis in Parkinson's disease. Quinn N. Neurology; 2000 May 09; 54(9):1877. PubMed ID: 10802809 [No Abstract] [Full Text] [Related]
19. Belladonna alkaloid psychosis: a study of scopolamine hydrobromide vs meths copolamine bromide. Kuhn JA, Savage GJ. Del Med J; 1974 May 09; 46(5):239-42. PubMed ID: 4830790 [No Abstract] [Full Text] [Related]